TASSO, MARCO
 Distribuzione geografica
Continente #
AS - Asia 1.728
NA - Nord America 1.265
EU - Europa 892
SA - Sud America 203
AF - Africa 35
Totale 4.123
Nazione #
US - Stati Uniti d'America 1.203
SG - Singapore 754
RU - Federazione Russa 484
CN - Cina 368
VN - Vietnam 258
IT - Italia 180
BR - Brasile 163
HK - Hong Kong 129
BD - Bangladesh 76
DE - Germania 52
FR - Francia 44
IN - India 32
CA - Canada 31
JP - Giappone 31
GB - Regno Unito 28
KR - Corea 23
IE - Irlanda 17
NL - Olanda 16
MX - Messico 15
AR - Argentina 14
ES - Italia 13
FI - Finlandia 12
PH - Filippine 9
PL - Polonia 9
CI - Costa d'Avorio 8
ZA - Sudafrica 8
IQ - Iraq 7
UA - Ucraina 7
ID - Indonesia 6
JM - Giamaica 6
PY - Paraguay 6
TN - Tunisia 6
EC - Ecuador 5
SE - Svezia 5
TR - Turchia 5
VE - Venezuela 5
AT - Austria 4
CO - Colombia 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PK - Pakistan 4
SA - Arabia Saudita 4
GR - Grecia 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
TW - Taiwan 3
UZ - Uzbekistan 3
BS - Bahamas 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
HR - Croazia 2
IL - Israele 2
MY - Malesia 2
OM - Oman 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
NA - Namibia 1
NP - Nepal 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TL - Timor Orientale 1
UY - Uruguay 1
Totale 4.123
Città #
Singapore 385
Ashburn 192
San Jose 180
Moscow 136
Hong Kong 124
Hefei 106
Ho Chi Minh City 92
Beijing 77
Santa Clara 75
Chandler 73
The Dalles 64
Hanoi 55
Lauterbourg 37
Tokyo 30
Naples 29
Los Angeles 26
Redondo Beach 22
Boston 21
Millbury 21
Seoul 21
New York 18
Dallas 17
Lawrence 17
Milan 17
Munich 15
São Paulo 15
Buffalo 14
Cava de' Tirreni 13
Des Moines 12
Nanjing 12
Amsterdam 11
Rome 11
Frankfurt am Main 10
Da Nang 9
Guangzhou 9
Hangzhou 9
Wilmington 9
Haiphong 8
Washington 8
Chicago 7
Hải Dương 7
Princeton 7
Seattle 7
Boardman 6
Dublin 6
Mexico City 6
Montreal 6
Orem 6
Toronto 6
Asunción 5
Brasília 5
Chennai 5
London 5
Mumbai 5
Napoli 5
Ottawa 5
Warsaw 5
Atlanta 4
Biên Hòa 4
Brno 4
Brooklyn 4
Council Bluffs 4
Denver 4
Florence 4
Helsinki 4
Johannesburg 4
Kingston 4
Mérida 4
Nanchang 4
Phoenix 4
Poplar 4
Shenyang 4
Sumaré 4
Vũng Tàu 4
Ankara 3
Baghdad 3
Barcelona 3
Campoli del Monte Taburno 3
Cassano d'Adda 3
Charlotte 3
Chengdu 3
Fairfield 3
Frisco 3
Guarulhos 3
Houston 3
Lima 3
Manchester 3
New Delhi 3
Ninh Bình 3
Nola 3
Quận Bình Thạnh 3
Redwood City 3
San Vicent del Raspeig 3
Secaucus 3
Springfield 3
Turku 3
Woodbridge 3
Wroclaw 3
Aracaju 2
Belém 2
Totale 2.248
Nome #
Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies 171
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 164
Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies 164
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 135
Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: A systematic review and meta-analysis of literature studies 127
Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies 126
Small molecule therapy for managing moderate to severe psoriatic arthritis 125
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 124
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 121
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 120
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 119
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 119
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 118
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 115
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 113
JAK Inhibitors in Psoriatic Disease 109
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 109
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 108
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain 107
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 100
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 98
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 95
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 95
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 89
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 87
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 87
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 86
Experimental and investigational pharmacotherapy for psoriatic arthritis: Drugs of the future 83
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 76
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study 73
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders 72
Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis 71
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 70
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 68
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 68
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 66
Rheumatologist’s Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 64
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 63
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 55
Assessing cardiovascular risk in rheumatoid arthritis patients on Janus kinase inhibitors: real-world data from the European Alliance of Associations for Rheumatology-adapted CUORE risk algorithm 54
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 52
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies 13
Intercepting the psoriasis-psoriatic arthritis continuum: a precision-medicine framework for at-risk, subclinical, and early psoriatic arthritis 11
Totale 4.207
Categoria #
all - tutte 13.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 3 0 0 1 2 1 8 13 14 24 50
2022/2023202 25 8 4 21 27 23 3 19 39 12 14 7
2023/2024205 6 19 10 11 15 51 7 41 2 3 21 19
2024/20251.188 100 73 17 27 16 78 149 76 48 97 425 82
2025/20262.314 235 221 251 216 333 113 226 167 235 115 80 122
2026/202745 45 0 0 0 0 0 0 0 0 0 0 0
Totale 4.207